We determined the configuration of the genes for the beta (Tb,.) and gamma (T,,,.) 
1. Abbreviations used in this paper: ALL, acute lymphoblastic leukemia; B-and T-ALL, B and T cell ALL; ATL, adult T cell leukemia; CLL, chronic lymphocytic leukemia; B-and T-CLL, B and T cell CLL; became important to establish if such rearranged T cell receptor genes were restricted to this pre-B cell lineage (ALL), or whether they could be demonstrated in mature B cell populations as well. We have therefore examined the status of the T cell receptor genes in 100 consecutive specimens of B cell lymphoma and chronic leukemia, and report here our failure to find a single adult B cell neoplasm with convincing rearrangement of both Tb,, and Tgamma genes.
Methods
Patients and surface marker analysis. An earlier publication (7) analyzed surface markers and Ig genes in 100 consecutive adult patients with non-Hodgkin's lymphoma or B cell chronic lymphocytic leukemia (B-CLL). Biopsy specimens were subclassified according to a modified Rappaport system for non-Hodgkin's lymphoma (8) , and the diagnosis of B-CLL was based on conventional morphologic criteria. The 100 cases were comprised of 32 of B-CLL, 23 of follicular lymphoma (lymphocytic or mixed), 23 of diffuse large cell lymphoma, 14 of diffuse poorly differentiated lymphocytic lymphoma, and 8 miscellaneous lymphomas. Lymphoblastic lymphoma and leukemias of T cell lineage were specifically excluded from this consecutive series. In all cases, lymphocyte surface markers were determined on suspensions prepared from fresh biopsy material (lymphoma) or Ficoll-Hypaque gradient-purified blood cells (leukemia).
Surface immunoglobulin (SIg) was assessed with a fluorescence microscope and fluorescein-conjugated heteroantisera specific for human IgM and IgG heavy chains, and the kappa and lambda light chains (Meloy Laboratories Inc., Springfield, VA). The suspensions were also evaluated with the following monoclonal antibodies: OKT4 (inducer-helper T cells); OKT8 (cytotoxic-suppressor T cells); OKT1 1 (sheep cell receptor); and B I (B cells). Except Bl, which was a product of Coulter Diagnostics (Hialeah, FL), the monoclonal antibodies were obtained from the Ortho Pharmaceutical (Raritan, NJ). The SIg was of kappa light chain type in 57 cases and lambda light chain type in 26: in the remainder a predominant light chain could not be determined. Details of the surface marker techniques employed are available in the earlier publication (7) .
A second series of cases, comprised of 18 consecutive patients with various T cell malignancies, was studied in similar fashion. The Tbt.
gene findings in three of these patients, case I in the cutaneous T cell lymphoma (CTCL), adult T cell leukemia (ATL), and T CLL categories, were described in an earlier report (2) .
Southern blot analysis of genomic DNA. High molecular weight DNA was prepared from each of the immunotyped specimens, and 6-10 1Ag was digested with appropriate restriction enzymes (New England Biolabs, Beverly, MA) and subjected to electrophoresis on 0.8% Fig. 2 , lanes 1-7), though a previously described polymorphism (13) represented by a 5.0-kb HindIII fragment was observed in two instances.
In Table III (Fig. 2, lanes 9-16) . However, EcoRI allowed easier identification of the particular rearranged Tg,,ma frag- 16) . DNA was digested with BamHI and hybridized with a probe specific for the joining region of the gamma chain of the T cell receptor. Lanes 1-7 contain DNA from the B cell lymphomas 1-7, respectively in Tables I and II , and is in germline configuration. Lane 8 is a DNA molecular weight marker expressed in kilobase. Lane 9-16 contain DNA derived from T cell neoplasms.
Case numbers from Table III 
Discussion
Clonal rearrangement of the gene for the beta chain of the T cell receptor is a regular finding in neoplasms of T cell lineage (1-3) . The question addressed in the present study is the specie; P, polymorphism; R, rearrangement. * The roman numerals desigficity ofthat finding to T cell lineage. The repeated observation of rearrangement of both Tbe and TPmma in non-T-, non-B-ALL (3-5, 14-16) indicates one instance of nonspecificity, but in certain respects that disorder is unique and may represent a special exception; i.e., ALL involves a stem cell that may retain the potential for both B-and T-lineage differentiation. Our findings in neoplasms of mature B cells suggest that the latter formulation is correct. Thus, in 100 consecutive specimens of adult B cell lymphoma and B-CLL we have not uncovered a single example of T cell receptor rearrangement comparable with those observed in the 18 T cell neoplasms. We have, to be sure, noted seven specimens with novel bands after BamHI digestion (a restriction enzyme that reliably picks up Tba rearrangements), but further study raises doubts that these are conventional rearrangements.
When compared with the T cell neoplasms, the Tb fragments in the B cell tumors are smaller in size and more restricted in size diversity, germline bands are always preserved and are usually of equal intensity to the novel bands, and a rearranged fragment usually (five ofseven instances) cannot be detected with restriction enzymes other than BamHI. Finally, the gene for the gamma chain ofthe T cell receptor is always in germline configuration with multiple restriction enzymes.
These several findings in B cell tumors contrast sharply with the observations in T cell lymphomas summarized in Table III . Every one of the 18 T cell neoplasms described therein has rearranged or deleted both alleles of the beta chain .._ool~~~~~~~~WI%. Table III are indicated in gene: in 15, both were rearranged, and in 3, one was rearranged and the other deleted. Further, the 11-kb EcoRI germline fragment containing the first constant region gene segment was never detected; both alleles had undergone either rearrangement or deletion. Finally, both alleles of the T .ma gene were in germline configuration in only one of the 18 T cell malignancies studied. Other investigators have also noted the regularity of Tgmma gene rearrangement in T cell neoplasia (13) (14) (15) .
Thus, the pattern of T cell receptor genes in the B cell lymphomas is not the ordered picture observed in T cell tumors. Rather, in the five cases in which rearrangement was observed with only one restriction enzyme (cases 1, 2, 3, 5, and 7 in Table II), the evidence favors an uncommon polymorphism of the Tb,.a gene. In the two cases in which a nongermline Tbeta fragment was observed with two restriction enzymes but in which Tgamma was in germline configuration (cases 4 and 6 in Table II) , it is uncertain whether a single allele of Tb,, has undergone an early (possible diversity-joining segment) rearrangement (17) or if this represents multiple polymorphisms. Unfortunately, the samples had been in storage for several years, and it was not possible to recall any of these patients to obtain additional material with which to establish the germline configuration in nonlymphoid tissue. These conclusions concerning the T cell receptor in B cell lymphoma differ from the conclusions of one group ofinvestigators based on preliminary findings (18) . Those workers report rearrangement of the gene for the beta chain of the T cell receptor in two ofseven cases of B cell lymphoma, and rearrangement of the gamma chain gene in six. It is not clear from the published report whether the Tb,,. rearrangements were confirmed with more than one restriction enzyme, raising the possibility that the reported bands were similar to those analyzed in the present study. Some of the reported Tgamma bands may represent the oligoclonal bands of nonneoplastic T cells, since T cells predominate in some monoclonal B cell tumors. The findings of another preliminary study (19) is in agreement with the present report.
We conclude from the foregoing that ordered rearrangement of the T cell receptor gene is rare in adult B cell lymphoma and B-CLL. In this respect, the findings differ from non-B-, non-T-ALL, a pre-B cell neoplasm. In that disorder, which like the adult B cell lymphomas under consideration exhibits rearranged Ig heavy chain genes (though usually not Ig kappa and Ig lambda) (6), 50% of cases rearrange one allele of Tpmma and about one-half of those also rearrange one Tba allele (3, 4, 14, 16) . The single case of non-T-, non-B-ALL reported by us (5) also exhibited one rearranged allele of Tb, and we record in Table III that one allele of Tgmn is also rearranged. Clearly, different genetic mechanisms are at work in B cell lymphoma and non-T-, non-B-ALL.
From the available evidence, T cell receptor gene configuration ofB and T cell neoplasms appears to be less inconsistent than was first feared when the findings in non-T-, non-B-ALL became available. T cell neoplasms always rearrange both alleles of Tbeta and almost always both alleles of Tgamma, whereas B cell neoplasms rearrange at least one (usually both) Ig heavy chain allele(s) and at least one Ig light chain allele. Common ALL antigen-positive non-T, non-B ALL is exceptional in having rearranged one Ig heavy chain allele (but rarely a light chain allele), and frequently Tgamma (about onehalf of the time) and Tb,, (one-quarter of the time) as well.
Perhaps, the lineage ofnon-T-, non-B-ALL is more appropriately defined as pre-B, pre-T rather than as pre-B alone.
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